Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Brain structure in juvenile-onset Huntington disease.

Tereshchenko A, Magnotta V, Epping E, Mathews K, Espe-Pfeifer P, Martin E, Dawson J, Duan W, Nopoulos P.

Neurology. 2019 Apr 10. pii: 10.1212/WNL.0000000000007355. doi: 10.1212/WNL.0000000000007355. [Epub ahead of print]

PMID:
30971481
2.

Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.

Ribaï P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dodé C, Brice A, Dürr A.

Arch Neurol. 2007 Jun;64(6):813-9.

PMID:
17562929
3.

Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.

Latimer CS, Flanagan ME, Cimino PJ, Jayadev S, Davis M, Hoffer ZS, Montine TJ, Gonzalez-Cuyar LF, Bird TD, Keene CD.

J Huntingtons Dis. 2017;6(4):337-348. doi: 10.3233/JHD-170261.

4.

Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume.

Nicolas G, Devys D, Goldenberg A, Maltête D, Hervé C, Hannequin D, Guyant-Maréchal L.

Am J Med Genet A. 2011 Apr;155A(4):815-8. doi: 10.1002/ajmg.a.33911. Epub 2011 Mar 15.

PMID:
21412977
5.

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.

Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC.

Parkinsonism Relat Disord. 2018 Jan;46:56-61. doi: 10.1016/j.parkreldis.2017.11.001. Epub 2017 Nov 2.

PMID:
29128164
6.

Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA.

Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45.

7.

Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.

Greven CU, Bralten J, Mennes M, O'Dwyer L, van Hulzen KJ, Rommelse N, Schweren LJ, Hoekstra PJ, Hartman CA, Heslenfeld D, Oosterlaan J, Faraone SV, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar JK.

JAMA Psychiatry. 2015 May;72(5):490-9. doi: 10.1001/jamapsychiatry.2014.3162.

PMID:
25785435
8.

Abnormal Weight and Body Mass Index in Children with Juvenile Huntington's Disease.

Tereshchenko A, McHugh M, Lee JK, Gonzalez-Alegre P, Crane K, Dawson J, Nopoulos P.

J Huntingtons Dis. 2015;4(3):231-238. doi: 10.3233/JHD-150152.

9.

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

J Huntingtons Dis. 2013;2(4):477-89. doi: 10.3233/JHD-130076.

10.

Family history in juvenile Huntington disease: do the signs point to "yes" or "very doubtful"?

Lehman RK, Nance M.

Neurology. 2013 Mar 12;80(11):976-7. doi: 10.1212/WNL.0b013e31828728ce. Epub 2013 Feb 6.

PMID:
23390171
11.

Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.

Jin J, Peng Q, Hou Z, Jiang M, Wang X, Langseth AJ, Tao M, Barker PB, Mori S, Bergles DE, Ross CA, Detloff PJ, Zhang J, Duan W.

Hum Mol Genet. 2015 May 1;24(9):2508-27. doi: 10.1093/hmg/ddv016. Epub 2015 Jan 21.

12.

Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.

Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, Damier P, Supiot F, Bachoud-Levi AC, Remy P.

JAMA Neurol. 2017 Sep 1;74(9):1088-1096. doi: 10.1001/jamaneurol.2017.1200.

13.

Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.

Ooms M, Rietjens R, Rangarajan JR, Vunckx K, Valdeolivas S, Maes F, Himmelreich U, Fernandez-Ruiz J, Bormans G, Van Laere K, Casteels C.

Neurobiol Aging. 2014 Dec;35(12):2858-2869. doi: 10.1016/j.neurobiolaging.2014.06.010. Epub 2014 Jun 16.

PMID:
25018107
14.

Striatal and white matter predictors of estimated diagnosis for Huntington disease.

Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M; PREDICT-HD Investigators and Coordinators of the Huntington's Study Group (HSG).

Brain Res Bull. 2010 May 31;82(3-4):201-7. doi: 10.1016/j.brainresbull.2010.04.003. Epub 2010 Apr 10.

15.

In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.

Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL.

Neurology. 2004 Sep 28;63(6):989-95.

PMID:
15452288
16.

Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Hedjoudje A, Nicolas G, Goldenberg A, Vanhulle C, Dumant-Forrest C, Deverrière G, Treguier P, Michelet I, Guyant-Maréchal L, Devys D, Gerardin E, Dacher JN, Vivier PH.

Pediatr Radiol. 2018 Sep;48(10):1463-1471. doi: 10.1007/s00247-018-4167-z. Epub 2018 Jun 20.

PMID:
29926145
17.

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM.

Neurology. 2003 May 27;60(10):1615-20.

PMID:
12771251
18.

Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.

Samadi P, Boutet A, Rymar VV, Rawal K, Maheux J, Kvann JC, Tomaszewski M, Beaubien F, Cloutier JF, Levesque D, Sadikot AF.

Genes Brain Behav. 2013 Feb;12(1):108-24. doi: 10.1111/j.1601-183X.2012.00858.x. Epub 2012 Nov 21.

19.

Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.

Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, Long JD, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group.

Biol Psychiatry. 2012 May 1;71(9):822-8. doi: 10.1016/j.biopsych.2011.07.030. Epub 2011 Sep 9.

20.

Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease.

Carroll JB, Lerch JP, Franciosi S, Spreeuw A, Bissada N, Henkelman RM, Hayden MR.

Neurobiol Dis. 2011 Jul;43(1):257-65. doi: 10.1016/j.nbd.2011.03.018. Epub 2011 Mar 31.

PMID:
21458571

Supplemental Content

Support Center